Hula for Parkinson's Disease
(PAHU Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on adding a hula program as a non-drug approach, so you may not need to change your medications, but it's best to confirm with the study team.
What data supports the effectiveness of the treatment Hula for Parkinson's Disease?
How is the Hula treatment for Parkinson's disease different from other treatments?
The Hula treatment for Parkinson's disease is unique because it incorporates dance as a form of therapy, similar to other dance programs like tango and ballroom dancing, which have shown benefits in improving mobility, balance, and well-being in people with Parkinson's. Unlike traditional drug treatments, this approach focuses on physical activity and social engagement to enhance quality of life.678910
What is the purpose of this trial?
Parkinson's improvement Activated by Hula Understanding (PAHU), a pilot study, will evaluate the feasibility of hula program on patients with Parkinson's disease (PD). Hula combines several aspects-moderate physical activity, cardiovascular risk reduction, social support opportunities, and other stress-reducing qualities that have potential to prevent further neurodegeneration, improve balance and mobility, help non-motor symptoms and quality of life of PD patients in a sustainable and relatable fashion. The investigators will create a hula program specifically to the needs of patients with PD with mobility difficulty as a non-pharmacological intervention and conduct a pilot study to test the feasibility of such program. The investigators will learn from leaders of the Dance for PD (NYC), an internationally acclaimed program offering a range of dance classes for PD patients), as well as other key informants. The investigators will create once a week hula program for 3 months for PD patients and assess the feasibility of such program. Participants will undergo motor testing before and after the hula program, and will be interviewed for their feedback.
Eligibility Criteria
This trial is for individuals over 25 years old with a primary diagnosis of idiopathic Parkinson's Disease, confirmed by a specialist. Participants should be at Hoehn and Yahr Stage 2.5 or below, meaning they can walk independently without balance issues, and must be able to give informed consent.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Hula Program
Participants engage in a hula program tailored for PD patients, consisting of one-hour sessions once a week for 3 months
Follow-up
Participants are monitored for safety and effectiveness after the hula program, including motor testing and interviews for feedback
Treatment Details
Interventions
- Hula for Parkinson's
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Hawaii
Lead Sponsor